News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - IPO
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014
Loxo Oncology (LOXO) Prices Upsized IPO At Midpoint Of The Range, $13 A Share 8/1/2014
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million 7/31/2014
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO 7/31/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
VBL Therapeutics Announces Pricing Of Initial Public Offering 7/31/2014
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares 7/31/2014
Sequenom Inc. (SQNM) Announces Closing Of Initial Public Offering 7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces $40 Million Offering Of Common Stock 7/30/2014
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering 7/30/2014
Intersect ENT Announces Closing Of Its Initial Public Offering 7/30/2014
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share 7/29/2014
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014
Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range 7/25/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results 7/24/2014
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week 7/22/2014
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO 7/22/2014
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share 7/21/2014
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014
Seres Health Makes Push For First Drug, And IPO, Of Microbiome Era 7/17/2014
Cambridge's SAGE Therapeutics Ups Proposed IPO Deal Size 7/17/2014
Absorbable Drugs Biotech Innocoll, Inc. Sets Terms For $75 Million IPO 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
Menlo Park's Intersect ENT Latest Health/Bio IPO To Lower Target 7/16/2014
Rare Disease Biotech Bio Blast Pharma Sets Terms For $40 Million IPO 7/16/2014
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/15/2014
Ear Disease Biotech Otonomy, Inc. Files For An $86 Million IPO 7/14/2014
Southern California's Auspex Pharmaceuticals Prices Public Offering, Aims To Raise $60.6 Million 7/11/2014
ErgoMed To List On AIM Next Week After Raising GBP11 Million 7/9/2014
Italian Drugmaker Rottapharm Sets Price Range For IPO 7/8/2014
Durham Drug Developer Viamet Pharmaceuticals Files For $75 Million IPO 7/8/2014
Colorado's GlobeImmune, Inc. (GBIM) Prices IPO At $10 A Share, Below Expectations 7/2/2014
Cambridge's Minerva Neurosciences, Inc. (NERV) Prices IPO Below Range, Debuts At $6 Per Share 7/1/2014
San Diego's Ambrx, Inc. Withdraws Planned $86 Million IPO, Citing Market Conditions 7/1/2014
Former Genzyme Corporation (GENZ) Subsidiary rEVO Biologics Files For $75 Million IPO 7/1/2014
Immuno-Oncology Biotech Affimed Therapeutics AG Files For $75 Million IPO 6/30/2014
Seattle's Immune Design Corporation (IMDZ) Files For $60 Million IPO 6/27/2014
Luye Pharma Group Ltd. To Stage $764 Million IPO In Hong Kong 6/23/2014
Kite Pharma, Inc. Ups Proposed Deal Size To $120 Million, Raising Price Range To $17 Per Share 6/20/2014
Zafgen (ZFGN) Announces Pricing of Initial Public Offering 6/19/2014
GW Pharmaceuticals Eyes $148 Million In NASDAQ Offering 6/19/2014
Fremont Biotech Ardelyx Inc. (ARDX) Prices IPO At $14 Per Share 6/19/2014
Orthocell IPO Opens 6/5/2014
Biotech Aldeyra Therapeutics (ALDX) Prices Mini-IPO 5/2/2014
After Three Delays, SCYNEXIS, Inc. (SCYX) Finally Goes IPO At $10 A Share 5/2/2014
Organ Recovery Biotech Angion Biomedica Corp. Files For A $35 Million IPO 4/15/2014
Cerulean Pharma Inc. (CERU) Announces Pricing Of Initial Public Offering 4/10/2014
Emeryville's Adamas Pharmaceuticals (ADMS) IPO Prices At $16, Low End Of Range 4/10/2014
Bay Area's Corium International, Inc. Schedules In A $60 Million IPO 4/3/2014
Novo Nordisk A/S (NVO)'s IT Unit Appoints Advisers For Possible IPO 3/18/2014
Brushing Off Clinical Setback, Cerulean Pharma Inc. Tees Up $75 Million IPO 3/11/2014
Egalet IPO Underwriters Exercise Over-Allotment Option 3/10/2014
Vancouver's Aquinox Pharmaceuticals (AQXP) Prices Upsized IPO At $11, Raises $46 Million 3/7/2014
Week In Review: Jiangsu Aosaikang Pharma Delays China IPO 1/20/2014
San Diego's Auspex Pharmaceuticals Sets Terms For $61 Million IPO 1/17/2014
Cancer Diagnostic Developer Microlin Bio, Files For $25 Million IPO 1/13/2014
Innate Immunotherapeutics Completes $10 Million IPO 12/18/2013
Xencor Prices Initial Public Offering 12/3/2013
Kindred Bio Announces Launch Of Initial Public Offering 12/2/2013
uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering 11/11/2013
Fate Therapeutics (FATE) Bombs in IPO Debut, Prices at Low End of Revised Range 10/3/2013
Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO 9/18/2013
Beijing Genomics Institute (BGI) Shenzhen Plans IPO 9/3/2013
Cellular Dynamics International Sets Terms for $50 Million IPO 7/10/2013
Esperion Therapeutics, Inc. Prices Upsized $70 Million IPO for Statin Alternative Work 6/27/2013
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 6/25/2013
Belgian Heart Drug Firm Cardio3 BioSciences Launches IPO 6/21/2013
Belgian Heart Drug Firm Cardio3 BioSciences Plans to IPO in Paris, Brussels 6/5/2013
BioAmber Inc. Announces Closing of Initial Public Offering 5/15/2013
Epizyme Files Registration Statement for Proposed Initial Public Offering 4/26/2013
Epizyme Files for IPO of Up to $69 Million 4/22/2013
Portola Pharmaceuticals, Inc. Files for $115 Million IPO 4/15/2013
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs 4/12/2013
TRT Chinese Medicines Expects to IPO on ChiNext 4/11/2013
Chimerix, Inc. Sets Terms for $85 Million IPO 4/2/2013
TetraPhase Pharmaceuticals, Enanta Pharmaceuticals, Inc. Prepare for IPOs 3/19/2013
Emergence-Backed Veeva Systems, Inc. Seen Seeking $2 Billion Valuation With IPO 3/12/2013
Bausch & Lomb Owners Shift Focus to IPO 1/29/2013
Quintiles Transnational Corp. Talking to Banks About an IPO 1/28/2013
IPO Could Value Pfizer Inc. (PFE)'s Zoetis at Up to $12.5 Billion 1/21/2013
China National Biotech Group's $1.5 Billion IPO is Rumored Again 1/15/2013
Pfizer Inc. (PFE) to Launch Animal-Health Unit IPO in Early 2013 12/14/2012
Quintiles Transnational Corp. is Considering a Multibillion Dollar IPO 9/25/2012
OvaScience, Founded by Sirtris Pharmaceuticals (SIRT) Vets, Plans IPO 8/30/2012
Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen 5/29/2012
Supernus Pharmaceuticals Announces Closing of Initial Public Offering 5/7/2012
Pfizer Inc. (PFE) May Unload Animal Health Unit in IPO 4/30/2012
Once Again, Fosun Pharma Plans Hong Kong IPO 2/9/2012
Foci Pharma to IPO in Shenzhen 12/6/2011
China National Biotech Group to IPO on the Hong Kong Exchange 11/7/2011
Horizon Pharma, Inc. Plans IPO this Week, Expected to Raise a $61 Million Stock Offering 7/26/2011
Novartis AG Broods Over a China IPO, CEO Says Drugmaker is Ready for More Deals 7/12/2011
Shandong Jincheng Pharma Completes $72 Million IPO 6/22/2011
Ambit Biosciences Withdraws IPO 6/9/2011
So Close They Can Taste It; NanoBio Corporation, Investors Eye Potential IPO 6/3/2011
Myriant Technologies LLC Files for $125 Million IPO 6/1/2011
Solazyme, Inc. IPO Nets up to $227 Million 5/27/2011
Advanced BioHealing, Inc. Plans $200 Million IPO 5/6/2011
Pfizer Inc. (PFE), Temasek to Invest in Shanghai Pharmaceutical Co., Ltd.'s IPO: Shanghai Pharma Share Sale to Raise $2.2 Billion 5/3/2011
Sagent Pharmaceuticals, Inc. Announces Closing of 5.75M Share IPO 4/27/2011
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds 4/20/2011
Sagent Pharmaceuticals, Inc. Announces Initial Public Offering 4/6/2011
Aldagen, Inc. (ALDH) Pulls $80.5 Million IPO 4/6/2011
Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M 4/4/2011
Israeli Life Sciences Boom; Exchange Draws Flood of IPOs; Some see Symptoms of a Bubble 4/1/2011
Solazyme, Inc. Proposes $100 Million IPO and Nasdaq Global Market Listing 3/15/2011
Rosetta Genomics Ltd. (ROSG) Announces IPO of Majority-Owned Subsidiary Rosetta Green in Israel 2/22/2011
Philogen S.p.A. IPO Pulled as Bayer Corporation (BAY) Exits Cancer Pact 2/15/2011
AcelRx Pharmaceuticals Prices IPO at $5, Below the Original $12-$14 Range 2/11/2011
Swiss-Italian Biotech, Philogen Eyes up to 65.3 Million Euros in IPO 2/10/2011
BG Medicine Announces Exercise of Underwriters’ Over-Allotment Option and Closing of Initial Public Offering 2/10/2011
Endocyte, Inc. Announces Closing of Initial Public Offering and Over-Allotment Option 2/9/2011
RedHill Biopharma Ltd. Announces Successful Completion of IPO 2/7/2011
MedQuist Holdings Inc. Announces Pricing of Its Initial Public Offering 2/7/2011
Endocyte, Inc. Raises $75M, Gains 12% After Cutting Price 2/4/2011
Pacira Pharmaceuticals, Inc. Raises $42M, Opens Flat Post-IPO After Slashing Price 2/3/2011
AcelRx Pharmaceuticals Prices IPO 1/24/2011
Al-Dorra Holdings to IPO New Pharmaceutical Subsidiary, Hail First Pharma Inc. 1/21/2011
Ventrus Biosciences, Inc.  (VTUS) Prices Initial Public Offering at $6 Per Share; Raising $17.4 Million 12/17/2010
BG Medicine IPO Expects $71M in IPO 12/13/2010
Anacor Pharmaceuticals, Inc. Completes $70 Million Initial Public Offering and Concurrent Private Placement 12/1/2010
Anacor Pharmaceuticals, Inc. Completes Reduced IPOs as US Stocks Slump 11/24/2010
CLARIS Lifesciences Gets Nod for Rs 300-Crore IPO 11/23/2010
Zogenix, Inc. Prices IPO Below Expectations 11/23/2010
Biotech Clarus Therapeutics Files for $86 Million IPO 11/23/2010
Japan's Otsuka Holding Company to Raise $2.8 Billion in Record Pharma IPO 11/12/2010
Complete Genomics, Inc. IPO Prices Below Range, Raises $54M 11/11/2010
GlaxoSmithKline (GSK) and Pfizer Inc. (PFE) Says Future IPO Possible For ViiV Healthcare 11/10/2010
Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering 11/8/2010
Zogenix, Inc. Sets IPO Range; Expects to Raise $78 Million 11/5/2010
Pacific Biosciences Raises $200 Million in U.S. IPO 10/27/2010
Aegerion Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering 10/25/2010
Zealand Pharma Mulls IPO, Seen Worth up to $560 Million 10/21/2010
Pacific Biosciences to Raise Up to $230 Million in IPO 10/5/2010
Amyris Raises $84.8M in IPO, Prices at $16, Well Below Expected Range 9/28/2010
Zogenix, Inc. Files for $90 Million IPO 9/9/2010
Russia's Pharmsynthez Plans £10.5 Million ($16.1 Million) IPO 9/1/2010
NuPathe Inc. Prices Shares of IPO at Scaled-back Price, Raising $50 Million 8/6/2010
Biotech Horizon Biopharm Files To Sell Up To $86.3 Mln In IPO 8/4/2010
Trius Therapeutics Set to go Public This Week 7/28/2010
Trius Therapeutics IPO Plans Back on Track 7/22/2010
Epocrates Inc. Files for $75 Million IPO 7/19/2010
PregLem SA Said to Hire Credit Suisse for Possible Initial Public Offering 7/9/2010
ReSearch Pharmaceutical Services (RPS), Inc. Files for up to $100 Million IPO 6/21/2010
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Announces Successful Completion of IPO 6/16/2010
Sichuan Kelun Pharma to Stage $735 Million IPO in Shenzhen 5/21/2010
Migraine Patch Maker NuPathe Inc. Files for $86.3M IPO 5/17/2010
Units Issued in CorMedix (CRMD) IPO to Separate on May 13, 2010 5/10/2010
Accretive Health Files for $200 Million IPO 5/4/2010
Codexis, Inc. (CDXS) Announces Pricing of Initial Public Offering 4/22/2010
Alimera Sciences (ALIM) Prices Low IPO 4/22/2010
Amyris Biotechnologies, Inc. to Raise up to $100 Million in IPO 4/19/2010
Alimera Sciences Expects IPO to Raise About $87 Million 4/19/2010
NPS Pharmaceuticals, Inc. (NPSP) Prices Public Offering of Common Stock; NPS Increases Size Of Offering; Priced At 12% Discount 4/16/2010
Tengion Inc. Completes Initial Public Offering 4/14/2010
Nycomed Still Plans IPO 4/12/2010
French Neovasc Inc. (NVC) Cuts IPO Ambitions 4/9/2010
Alimera Sciences Files for $87 Million IPO 4/7/2010
Tengion Inc. Expects to Raise up to $44.4 Million in IPO 4/6/2010
Ironwood Pharmaceuticals Chief Executive Breaks Silence on IPO 3/29/2010
CorMedix Announces Pricing of Its Initial Public Offering 3/26/2010
Somaxon Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock 3/26/2010
Dyax Corp. (DYAX) Announces Pricing of Public Offering of Common Stock; Expects To Raise $51 Million 3/25/2010
French Biotech Neovacs SA Targets 20 Million Euros in IPO 3/19/2010
AVEO Pharmaceuticals, Inc. (AVEO) Announces Pricing of Its Initial Public Offering 3/12/2010
Anthera Pharmaceuticals, Inc. Completes Initial Public Offering 3/5/2010
AgraQuest, Inc. Strengthens Financial Standing Ahead of Planned IPO 3/4/2010
Anthera Pharmaceuticals, Inc. (JOBS) IPO Closes Up 1 Cent in The Nasdaq Stock Market -- New York Debut 3/2/2010
AVEO Pharmaceuticals, Inc. (AVEO) Sets IPO Terms 2/24/2010
Anthera Pharmaceuticals, Inc. Seeks IPO for Company With No Sales as Offerings Slump 2/22/2010
Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering 2/16/2010
Belgium's Taminco Cancels IPO, Cites Poor Market 2/4/2010
Ironwood Pharmaceuticals IPO Raises Less Than Expected-Says Underwriter 2/3/2010
Anthera Pharmaceuticals, Inc. Sets IPO Terms, Will Price in the $13-$15 Per Share Range 2/3/2010
Ironwood Pharmaceuticals Sets IPO Price at $14-$16 Per Share to Raise Between $233 Million and $267 Million 1/20/2010
Med BioGene Files Registration Statement for Proposed $24.25M U.S. IPO 12/30/2009
U.S. Biotech Codexis Pharmaceuticals Files for $100 Million IPO 12/30/2009
Tengion Inc. Files $40.25 Million IPO 12/28/2009
AVEO Pharmaceuticals, Inc. Files Registration Statement for Initial Public Offering 12/17/2009
China Nuokang Bio-Pharmaceutical Inc. (NKBP) IPO Prices Below Range, Raises $45 Million 12/10/2009
Movetis Seeking up to 112.4 Million Euros in IPO 11/20/2009
Trius Therapeutics Files for IPO 11/9/2009
Alimera Sciences (ALIM) Re-Files for IPO 11/2/2009
Aldagen, Inc. (ALDH) Files for $80.5 Million IPO 10/30/2009
Omeros Corporation, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/9/2009
Omeros Corporation Raises $68.2M in Washington's First IPO in Two Years 10/8/2009
Talecris Biotherapeutics (TLCR) (JOBS) Raises $950 Million in Biggest Biopharma IPO in Three Years 10/2/2009
Omeros Corporation Announces IPO of 6.8 Million Shares 9/18/2009
Omeros Corporation Moves Closer To IPO, Sets Price Goal 9/17/2009
Anthera Pharmaceuticals, Inc. Plans $70 Million IPO 9/16/2009
Talecris Biotherapeutics (TLCR) (JOBS) Plans IPO 9/15/2009
Sinopharm IPO to Raise up to $1.13 Billion 9/4/2009
Omeros Corporation Plans to Test Waters with First Washington IPO in Two Years, Sources Say 8/27/2009
D-Pharm Ltd. Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 8/17/2009
Cheezheng Tibetan Medicine to IPO on Shenzhen Exchange 8/13/2009
Emdeon Corporation (HLTH) IPO Rises 6.6%, Ending Off Day's High 8/13/2009
Talecris Biotherapeutics (JOBS) Still Planning IPO 8/3/2009



//-->